Cite
HARVARD Citation
Sasaki, K. et al. (2019). Sorafenib plus intensive chemotherapy improves survival in patients with newly diagnosed, FLT3‐internal tandem duplication mutation–positive acute myeloid leukemia. Cancer. 125 (21), pp. 3755-3766. [Online].